New Pills for Poor People? Empirical Evidence after GATT

By J. Lanjouw, Iain M. Cockburn. 2001

149 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Management of Technology and Innovation

View Paper: https://www.semanticscholar.org/paper/7bdf2e3a9bb5b920f19e7123d88fddb3c654dd47

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. G. Jefferson
2. Albert G Z Hu
3. P. Fowler
4. K. Watkins
5. Xibao Li
6. Ping Lin
7. Yundan Gong
8. Debin Du

In Management of Technology and Innovation

1. Albert G Z Hu

Citations in the corpus

• Rigged Rules and Double Standards: Trade, Globalisation, and the Fight Against Poverty (2002, background): “Implications for the price of medicine Until the early 1990s, approximately 50 developing countries either excluded medicines from eligibility for product patents, or provided shorter periods of protection, or operated conditions which restricted the claims of patent holders (Lanjouw and Cockburn 20”
• A great wall of patents: What is behind China's recent patent explosion? (2009, background): “Lanjouw and Cockburn (2001) focused on the response of the global pharmaceutical industry to the trend of strengthening IPR, including in the developing economies that started with GATT negotiations in the mid 1980s.”